Skip Nav Destination
Article navigation
Meeting Abstracts|
September 2000
Room B, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Reducing the Incidence of Heparin Resistance: An Evidence-Based Guideline for Heparin Dosing for Cardiopulmonary Bypass : A-206
Dept. of Anes. and Critical Care, Mass. Gen. Hospital, Boston, MA, United States.
Anesthesiology September 2000, Vol. 93, A–206.
Citation
Thomas G. Standl, Yu Chiao Chang, Sandra de-Bronkart, Derrick B. Willsey, Michael N. D'Ambra; Room B, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Reducing the Incidence of Heparin Resistance: An Evidence-Based Guideline for Heparin Dosing for Cardiopulmonary Bypass : A-206. Anesthesiology 2000; 93:A–206 doi: https://doi.org/10.1097/00000542-200009001-00206
Download citation file:
121
Views
Citing articles via
Most Viewed
Related Articles
Influence of High-dose Aprotinin on Anticoagulation, Heparin Requirement, and Celite- and Kaolin-Activated Clotting Time in Heparin-pretreated Patients Undergoing Open-Heart Surgery: A Double-blind, Placebo-controlled Study
Anesthesiology (October 1995)
Reliability of the Heparin Management Test for Monitoring High Levels of Unfractionated Heparin: In Vitro Findings in Volunteersversus In Vivo Findings during Cardiopulmonary Bypass
Anesthesiology (June 2000)
Heparin-Protamine Complexes Cause Pulmonary Hypertension in Goats
Anesthesiology (October 1995)
A Phase III, Double-blind, Placebo-controlled, Multicenter Study on the Efficacy of Recombinant Human Antithrombin in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
Anesthesiology (February 2005)
Protamine-induced Cardiotoxicity Is Prevented by Anti-TNF-α Antibodies and Heparin
Anesthesiology (December 2001)
